{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "EUR", "exchange": "FRA", "shortName": "PHARMIVA AB", "longName": "Pharmiva AB (publ)", "messageBoardId": "finmb_534571564", "exchangeTimezoneName": "Europe/Berlin", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "market": "dr_market", "esgPopulated": false, "regularMarketChangePercent": -2.4144828, "regularMarketPrice": 0.097, "marketState": "REGULAR", "firstTradeDateMilliseconds": 1617688800000, "priceHint": 4, "epsTrailingTwelveMonths": -0.21, "sharesOutstanding": 17376000, "fiftyDayAverage": 0.11637, "fiftyDayAverageChange": -0.019369997, "fiftyDayAverageChangePercent": -0.16645181, "twoHundredDayAverage": 0.132846, "twoHundredDayAverageChange": -0.035845995, "twoHundredDayAverageChangePercent": -0.2698312, "marketCap": 1912723, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "prevName": "Pharmiva AB", "nameChangeDate": "2023-05-11", "tradeable": false, "cryptoTradeable": false, "regularMarketChange": -0.002399996, "regularMarketTime": 1683871386, "regularMarketDayHigh": 0.097, "regularMarketDayRange": "0.097 - 0.097", "regularMarketDayLow": 0.097, "regularMarketVolume": 5014, "regularMarketPreviousClose": 0.0994, "bid": 0.1025, "ask": 0.123, "fullExchangeName": "Frankfurt", "financialCurrency": "SEK", "regularMarketOpen": 0.097, "averageDailyVolume3Month": 0, "averageDailyVolume10Day": 0, "fiftyTwoWeekLowChange": 0.0362, "fiftyTwoWeekLowChangePercent": 0.59539473, "fiftyTwoWeekRange": "0.0608 - 0.518", "fiftyTwoWeekHighChange": -0.421, "fiftyTwoWeekHighChangePercent": -0.81274134, "fiftyTwoWeekLow": 0.0608, "fiftyTwoWeekHigh": 0.518, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "symbol": "958.F"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "Sankt Lars VAeg 45B", "city": "Lund", "zip": "22270", "country": "Sweden", "phone": "46 4 62 86 51 00", "website": "https://www.pharmiva.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Pharmiva AB (publ) engages in the research and development of medical products. The company develops Vernivia, an over-the-counter vaginal mousse for the treatment of bacterial vaginosis. Pharmiva AB (publ) is based in Lund, Sweden.", "fullTimeEmployees": 6, "companyOfficers": [{"maxAge": 1, "name": "Ms. Anna  Linton", "age": 51, "title": "Chief Exec. Officer", "yearBorn": 1971, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Per-Ola  Forsberg", "age": 61, "title": "Chief Financial Officer", "yearBorn": 1961, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "maxAge": 86400}}], "error": null}}